Autopsy report · NCT06451835

Evaluation of Response to a Course of Repetitive Transcranial Magnetic Stimulation Using Vocal Biomarkers

“We are faced with a decrease in rTMS activity at the study sites, as well as problems with the active file meeting the protocol inclusion criteria, resulting in a low recruitment rate and an extended study timetable, forcing us to suspend this study.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 156 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

GCS CIPS

Sponsor type

University, hospital or other

Conditions

Major Depressive Disorder

Interventions

repetitive transcranial magnetic stimulation (rTMS)

Participants

156 (planned, not actual)

Sites

9

Countries

France

Trials that died the same way

• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
  “Management decision to suspend the study due to recruitment issues” (58% match in meaning)
• Study of Fish Oil to Reduce ALT Levels in Adolescents
  “Study closed for slow recruitment” (56% match in meaning)
• Pituitary Function and Spontaneous Intracranial Hypotension
  “Study protocol needs to be amended. Recruitment is halted until amendment is completed and approved by IRB.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.